T1	Participants 46 86	non-insulin-dependent diabetes mellitus.
T2	Participants 222 347	dyslipidemic patients with non-insulin-dependent diabetes mellitus, 13 patients were treated in a randomized crossover trial.
T3	Participants 1311 1319	patients
T4	Participants 1459 1513	patients with non-insulin-dependent diabetes mellitus.
